See more news releases in: Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals
Mylan to Host Investor Day on Feb. 21, 2012, in New York City
NEW YORK, Jan. 24, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) will host an Investor Day on Feb. 21, in New York City. Robert J. Coury, Mylan's executive chairman; Heather Bresch, chief executive officer; Rajiv Malik, president; Hal Korman, chief operating officer; John Sheehan, chief financial officer; and John Thievon, president of Dey Pharma, will present the company's financial guidance for 2012 and an overview of the company's strategic vision and growth strategy for 2013 and beyond. They will be joined by Tony Mauro, president of North America, and Didier Barret, president of Mylan's Europe, Middle East and Africa operations, for a question and answer session.
The presentations will be broadcast live via webcast beginning at 1 p.m. ET. The meeting is expected to conclude by 5 p.m. ET.
The company will issue its fourth quarter and full-year 2011 earnings results before the market opens on Feb. 21.
To access the live webcast and view the accompanying slide presentations, visit the Investor Relations section of Mylan's website, at http://investor.mylan.com, at least 15 minutes before the presentation is scheduled to begin; click on the webcast icon to register and download or install any necessary software. If you are unable to view the live webcast, a replay will be available for 30 days on Mylan's website after the event's conclusion.
Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.
SOURCE Mylan Inc.
Back to top
RELATED LINKS
http://www.mylan.com
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
PR Newswire Membership
Fill out a PR Newswire membership form or contact us at (888) 776-0942.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
Featured Video
More in These Categories
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Free Investing Newsletter from Investor Uprising!
Learn to navigate the world's financial system and profit from leading companies.
Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All That Glitters: The Ultimate Gold Report".
- Site Preview
-
Close Site Preview
-
View FullScreen

